| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 24 |
| 1 | DEXAMETHASONE | 16 |
| 2 | DEXAMETHASONE 1.5 MG | 16 |
| 3 | METHYLPREDNISOLONE | 16 |
| 4 | PANTOPRAZOLE | 16 |
| 5 | POTASSIUM CHLORIDE | 15 |
| 6 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 14 |
| 7 | POTASSIUM CHLORIDE ORAL | 14 |
| 8 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 14 |
| 9 | ACETAMINOPHEN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NYSTATIN AND TRIAMCINOLONE ACETONIDE | 1 | 0.0095 |
| 1 | NYSTATIN, TRIAMCINOLONE ACETONIDE | 1 | 0.0092 |
| 2 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 1 | 0.0047 |
| 3 | COLLOIDAL OATMEAL | 1 | 0.0039 |
| 4 | MANNITOL | 12 | 0.0024 |
| 5 | REMIBRUTINIB | 3 | 0.0022 |
| 6 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 7 | APREPITANT | 13 | 0.0017 |
| 8 | ALEMTUZUMAB | 24 | 0.0012 |
| 9 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 44 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 24 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 3 | Osmotic Laxative [EPC] | 20 |
| 4 | Atypical Antipsychotic [EPC] | 18 |
| 5 | Platinum-based Drug [EPC] | 17 |
| 6 | Kinase Inhibitor [EPC] | 14 |
| 7 | Potassium Salt [EPC] | 14 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 14 |
| 9 | Benzodiazepine [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Osmotic Diuretic [EPC] | 12 | 0.0023 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 13 | 0.0015 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 24 | 0.0012 |
| 3 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 4 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0003 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 4 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Estrogen Receptor Antagonist [EPC] | 6 | 0.0001 |